Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 890 results found since Jan 2013.
Apical Lung Exam on CTA Aids COVID-19 Screen in Stroke Patients
THURSDAY, Oct. 29, 2020 -- For patients presenting with acute ischemic stroke (AIS), apical lung assessment on computed tomography angiography (CTA) may be useful as part of the screening approach for COVID-19, according to a study published online...
Source: Drugs.com - Pharma News - October 29, 2020 Category: Pharmaceuticals Source Type: news
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation
MARLBOROUGH, Mass., Oct. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporatio... Devices, Interventional, Cardiology Boston Scientific, WATCHMAN FLX, Left Atrial Appendage, atrial fibrillation
Source: HSMN NewsFeed - October 29, 2020 Category: Pharmaceuticals Source Type: news
Many U.S. Young Adults Not Aware of Stroke Symptoms
TUESDAY, Oct. 27, 2020 -- A considerable proportion of young adults are not aware of stroke symptoms, according to a study published online Oct. 26 in Stroke.
Reed Mszar, M.P.H., from the Yale School of Public Health in New Haven, Connecticut, and...
Source: Drugs.com - Pharma News - October 27, 2020 Category: Pharmaceuticals Source Type: news
Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revascularization, a c...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Weekend Admission Tied to Higher Stroke Mortality
WEDNESDAY, Oct. 21, 2020 -- Patients admitted for hemorrhagic stroke on weekends have higher in-hospital mortality than those admitted on weekdays, according to a study published in the October issue of the Journal of Stroke& Cerebrovascular...
Source: Drugs.com - Pharma News - October 21, 2020 Category: Pharmaceuticals Source Type: news
Cannabis Use Not Associated With Increased Risk For Ischemic Stroke In Recent Study
A new study from the University of Mississippi found no evidence for the supposed connection; adding to the research suggesting that cannabis is not an independent risk factor for ischemic stroke.
Source: Forbes.com Healthcare News - October 13, 2020 Category: Pharmaceuticals Authors: Emily Earlenbaugh, Contributor Tags: Vices /vices Lifestyle /lifestyle Innovation /innovation Healthcare /healthcare Source Type: news
Johnson & Johnson Reports 2020 Third-Quarter Results
New Brunswick, N.J. (October 13, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. “Our third-quarter results reflect solid performance and positive trends across Johnson & Johnson, powered by better-than-expected procedure recovery in Medical Devices, growth in Consumer Health, and continued strength in Pharmaceuticals,” said Alex Gorsky, Chairman and Chief Executive Officer. “I am proud of the relentless passion and Credo-led commitment to patients and customers that our colleagues around the world continue to demonstrate as we boldly fight the COVID-19 pandemic. Our wo...
Source: Johnson and Johnson - October 13, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news
U.S. Presidential Election Linked To More Heart Attacks And Strokes, Study Finds
Heart attack and stroke hospitalisations doubled in the two days immediately after the 2016 presidential election, according to a new study.
Source: Forbes.com Healthcare News - October 12, 2020 Category: Pharmaceuticals Authors: Misha Gajewski, Contributor Tags: Healthcare /healthcare Innovation /innovation Money /money Election 2020 /election-2020 Source Type: news
Election 2020: Prop. 14 would boost funding on stem-cell research
It would dedicate $1.5 billion of its total to research and therapy for Alzheimer ’s Disease, Parkinson’s Disease, stroke, epilepsy and other brain and central nervous system conditions.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 9, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Remote Ischemic Postconditioning May Aid Stroke Recovery
THURSDAY, Oct. 8, 2020 -- For patients with acute ischemic stroke (AIS) undergoing intravenous thrombolysis (IVT), remote ischemic postconditioning (RIPC) is associated with improved clinical prognosis, according to a study published online Oct. 7...
Source: Drugs.com - Pharma News - October 8, 2020 Category: Pharmaceuticals Source Type: news
Home-Based Telerehabilitation Beneficial for Stroke Patients
THURSDAY, Oct. 1, 2020 -- Home-based motor training telerehabilitation is beneficial for stroke patients, with enhanced interhemispheric functional connectivity of the M1 areas, according to a study published online Sept. 30 in Neurology.
Jing...
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news
AI Technology Can Help Speed Up Stroke Diagnosis And Treatment
A type of artificial intelligence known as deep learning can accurately use CT scan images to pick up blockages in the arteries that supply blood to the brain, which cause a large percentage of strokes.
Source: Forbes.com Healthcare News - September 30, 2020 Category: Pharmaceuticals Authors: Helen Albert, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Stroke, CVD Risk Up With Two or More Menopausal Symptoms
MONDAY, Sept. 28, 2020 -- Having two or more moderate or severe menopausal symptoms (MS) is associated with an increased risk for stroke and cardiovascular disease (CVD), according to a study presented at the annual meeting of the North American...
Source: Drugs.com - Pharma News - September 28, 2020 Category: Pharmaceuticals Source Type: news
Stroke ' Alarm Clock ' Improves Acute Stroke Management Metrics
THURSDAY, Sept. 24, 2020 -- Use of a stroke alarm clock demanding active feedback significantly improves management metrics for acute stroke, according to a study published online Sept. 24 in Stroke.
Mathias Fousse, M.D., from the Saarland...
Source: Drugs.com - Pharma News - September 24, 2020 Category: Pharmaceuticals Source Type: news
Strokes: know the signs and call 911
Getting the right care in a timely manner is important in medical emergencies. In the event that you or a loved one suffers a stroke, time is especially critical.
“In the event of a stroke, a delay of only 15 minutes in treatment greatly decreases your chances not only of making a full recovery, but also being able to walk or live independently, and in many cases, of survival,” says Christopher Zammit, MD, a critical care specialist and emergency physic ian with TriHealth, which offers a network…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 23, 2020 Category: Pharmaceuticals Authors: TriHealth Source Type: news
